Omitting radiation to the lower-neck region in patients with early-stage nasopharyngeal cancer provided similar survival outcomes and reduced long-term toxicity compared to whole-neck irradiation.
A palliative Quad Shot radiotherapy regimen alongside concurrent immunotherapy can improve local control in symptomatic patients with head and neck cancer but may not improve overall survival.
For the first time, new research shows that taking a specific class of migraine medication during the prodromal phase reduces the development and severity of the subsequent headache.
With no apparent benefit for most, investigators say routine surveillance imaging in asymptomatic patients with head and neck cancer "should be discouraged."